
A promising cancer immunotherapy target: Novel agonistic human antibody against the human T-cell costimulatory receptor CD27
Thierry Guillaudeux, Phd, Chief Scientific Officer American Association for Cancer Research (AACR) Virtual Special Conference on Tumor Immunology and Immunotherapy | October 5-6, 2021